Augtyro
Active substance: repotrectinib
CAPSULE · REPOTRECTINIB 40 mg/1
United StatesActive
Marketing holder: E.R. Squibb & Sons, L.L.C.
Verified 2026-10-09 · openFDA NDC
Analogues in other countries- Source: openFDA NDC
- Countries with the substance registered: 2
Composition
- REPOTRECTINIB · 40 mg/1
Analogues by country
Products with the same active substance registered in other countries.
| Country | Products |
|---|---|
| EU 1 |
|
Import and control
Control by country
- United Statesprescription only
Source: openFDA NDC · record 01a12095-823f-79db-a907-ff3bb58e2ac0,01a1209a-c7bc-7576-b6c9-2ac76cedfde6;count=2 · valid from 2026-10-09 · verified 2026-10-09
Registration
- Registration number
- 0003-4040
- Registration status
- Active
- Dispensing
- Prescription only
- Route
- ORAL
Sources
- product · openFDA NDC · 0003-4040 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 0003-4040 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 0003-4040 · Verified 2026-10-09 · open in source